The nation of Zimbabwe has turned down a major American healthcare agreement worth $367m (£272m) spanning five years due to the United States' demand for confidential data.
The decision came to light following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "skewed".
An official spokesman later stated that the United States was requesting health data for scientific study and commercial purposes while was unwilling to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued negotiations to secure a deal agreeable to all parties so the nation's vital HIV programme can continue.
Wider Background
This development comes after a comparable case in neighbouring Kenya, where a high court halted a related health funding agreement following legal challenges were filed about the security of citizens' health data.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
Based on reports, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," the Ambassador said.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that shared data," Mangwana explained.
"In essence, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our citizens should a future health crisis arise."
Sovereignty and Global Health
He also said that the American exit from the global health body and its push of one-on-one health agreements were undermining structures previously set up through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to deal with future pandemics.
"This system is designed to ensure that when a nation contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome continued dialogue with our US partners on how subsequent collaboration might be designed in a manner that honours the independence and dignity of both nations."
Medical Community Response
Medical experts stated it understood the official position, but suggested that talks must proceed considering a large portion of the country's Aids initiatives were funded by foreign aid.
"Where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
The halted deal emphasises the complex tensions between accepting vital international aid and safeguarding local interests in an increasingly data-driven world.